BioCentury | Dec 9, 2020
Product Development

Dec. 8 Quick Takes: Amgen’s KRAS inhibitor nears FDA submission; plus Curis, BeiGene, Pfizer, Forma, Agios, Lyra, Bellicum, Illumina-Harvard Pilgrim

...the primary endpoint in the Phase II LANTERN trial of LYR-210 to treat chronic rhinosinusitis, Lyra Therapeutics Inc....
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...Kite Pharma Inc. unit of Gilead Sciences Inc. (NASDAQ:GILD). Ear, nose and throat diseases company Lyra Therapeutics Inc....
...Sawka, BioCentury Staff Akcea Therapeutics Inc. ImCheck Therapeutics S.A.S. IsoPlexis Corp. Abeona Therapeutics Inc. Evaxion Biotech A/S Strongbridge Biopharma plc Sotio a.s. Rexgenero Ltd. Lyra Therapeutics Inc. ImmunoMolecular...
BioCentury | Jun 6, 2020
Finance

Daily Chart: NASDAQ’s dazzling debuts

...Wolfe, Associate Editor, Data & Analytics Legend Biotechnology Co. Ltd. Applied Molecular Transport Inc Pliant Therapeutics Inc. Ayala Pharmaceuticals Inc. Lyra Therapeutics Inc. ORIC...
BioCentury | May 15, 2020
Finance

As biotech IPO pace quickens, ADC Therapeutics garners largest postmoney valuation of the year

...Pharmaceuticals Inc. (NASDAQ:AYLA) priced a bumped-up offering at its midpoint last week, while ENT company Lyra Therapeutics Inc....
BioCentury | May 11, 2020
Finance

Third Rock-backed fibrosis company Pliant joins IPO queue

...Inc. (NASDAQ:AYLA) priced a bumped-up offering at its midpoint last week, while chronic rhinosinusitis company Lyra Therapeutics Inc....
BioCentury | May 9, 2020
Finance

Ayala becomes latest to join the year’s bumper crop of biopharma IPOs

...in 2019 (see “Follow-on Market Poised for Comeback” ). Ayala’s public debut follows that of Lyra Therapeutics Inc....
BioCentury | May 5, 2020
Finance

May 4 Quick Takes: Following Lyra’s success, Ayala readies for NASDAQ IPO; plus Medable and Hyloris

...Ayala would raise $49.5 million and be valued at $181.7 million. The filing comes after Lyra Therapeutics Inc....
BioCentury | May 1, 2020
Finance

As market’s upbeat April draws to close, Lyra becomes latest biotech IPO to surge

...in the final hours of a month in which biotech indexes climbed by double digits. Lyra Therapeutics Inc....
...the Dow Jones Industrial Average gained 11%, while the NASDAQ Composite rose 15%. Paul Bonanos, Associate Editor Lyra Therapeutics Inc. IPO...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...and begin construction of a GMP facility. Lyra sets terms for planned IPO Rhinosinusitis company Lyra Therapeutics Inc....
...a 47.6% stake in Immunomic. Five members of HLB Co. Ltd. will join Immunomic’s board. BioCentury Staff Lyra Therapeutics Inc. HebeCell...
BioCentury | Apr 24, 2020
Finance

Big gain for ORIC in trading debut after pricing upsized IPO

...“Passage Prices Despite Headwinds” ). Elsewhere in the queue are Ayala Pharmaceuticals Inc. and Lyra Therapeutics Inc....
Items per page:
1 - 10 of 26
BioCentury | Dec 9, 2020
Product Development

Dec. 8 Quick Takes: Amgen’s KRAS inhibitor nears FDA submission; plus Curis, BeiGene, Pfizer, Forma, Agios, Lyra, Bellicum, Illumina-Harvard Pilgrim

...the primary endpoint in the Phase II LANTERN trial of LYR-210 to treat chronic rhinosinusitis, Lyra Therapeutics Inc....
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...Kite Pharma Inc. unit of Gilead Sciences Inc. (NASDAQ:GILD). Ear, nose and throat diseases company Lyra Therapeutics Inc....
...Sawka, BioCentury Staff Akcea Therapeutics Inc. ImCheck Therapeutics S.A.S. IsoPlexis Corp. Abeona Therapeutics Inc. Evaxion Biotech A/S Strongbridge Biopharma plc Sotio a.s. Rexgenero Ltd. Lyra Therapeutics Inc. ImmunoMolecular...
BioCentury | Jun 6, 2020
Finance

Daily Chart: NASDAQ’s dazzling debuts

...Wolfe, Associate Editor, Data & Analytics Legend Biotechnology Co. Ltd. Applied Molecular Transport Inc Pliant Therapeutics Inc. Ayala Pharmaceuticals Inc. Lyra Therapeutics Inc. ORIC...
BioCentury | May 15, 2020
Finance

As biotech IPO pace quickens, ADC Therapeutics garners largest postmoney valuation of the year

...Pharmaceuticals Inc. (NASDAQ:AYLA) priced a bumped-up offering at its midpoint last week, while ENT company Lyra Therapeutics Inc....
BioCentury | May 11, 2020
Finance

Third Rock-backed fibrosis company Pliant joins IPO queue

...Inc. (NASDAQ:AYLA) priced a bumped-up offering at its midpoint last week, while chronic rhinosinusitis company Lyra Therapeutics Inc....
BioCentury | May 9, 2020
Finance

Ayala becomes latest to join the year’s bumper crop of biopharma IPOs

...in 2019 (see “Follow-on Market Poised for Comeback” ). Ayala’s public debut follows that of Lyra Therapeutics Inc....
BioCentury | May 5, 2020
Finance

May 4 Quick Takes: Following Lyra’s success, Ayala readies for NASDAQ IPO; plus Medable and Hyloris

...Ayala would raise $49.5 million and be valued at $181.7 million. The filing comes after Lyra Therapeutics Inc....
BioCentury | May 1, 2020
Finance

As market’s upbeat April draws to close, Lyra becomes latest biotech IPO to surge

...in the final hours of a month in which biotech indexes climbed by double digits. Lyra Therapeutics Inc....
...the Dow Jones Industrial Average gained 11%, while the NASDAQ Composite rose 15%. Paul Bonanos, Associate Editor Lyra Therapeutics Inc. IPO...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...and begin construction of a GMP facility. Lyra sets terms for planned IPO Rhinosinusitis company Lyra Therapeutics Inc....
...a 47.6% stake in Immunomic. Five members of HLB Co. Ltd. will join Immunomic’s board. BioCentury Staff Lyra Therapeutics Inc. HebeCell...
BioCentury | Apr 24, 2020
Finance

Big gain for ORIC in trading debut after pricing upsized IPO

...“Passage Prices Despite Headwinds” ). Elsewhere in the queue are Ayala Pharmaceuticals Inc. and Lyra Therapeutics Inc....
Items per page:
1 - 10 of 26